Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discover effective ways to increase your investment portfolio performance. Enhance your returns and achieve your financial goals.
23,604 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Grok AI’s forecast of a $40K Bitcoin price has ignited a fierce market debate. Analysts say the model’s ultra-bear ca...
KAST announces an $80 million Series A led by QED Investors and Left Lane Capital, valuing the stablecoin fintech at ...
Oakmark Select adds to discounted stocks in Q4, signaling a shift toward durable earnings as volatility persists. Nyg...
Amazon unveils a bold plan to expand Leo satellites, targeting 1 Gbps speeds and enterprise deals that could disrupt ...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
A 67-year-old with $620,000 inherited 401(K) confronts a looming tax bill under the SECURE Act, turning a windfall in...
As AI reshapes the job market and tuition costs rise, the debate over whether the college degree still worth the cost...
Jeff Immelt debuts a Substack column to speak openly about GE’s legacy and his life after the helm. The move mirrors ...
OneTrust’s Gabe Bodner is shifting reverse mortgage sales toward wealthy retirees, framing the product as a wealth-ma...
When a software icon trades at a discount to cash flow, investors ask one simple question: is this a bargain or a tra...
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...